Archives for December 2, 2022

← 2022

ADDF: Anti-amyloids are a promising starting point

02-Dec-2022

By Jane Byrne

The phase 3 trial results for lecanemab and gantenerumab presented at the Clinical Trials on Alzheimer’s Disease (CTAD) conference demonstrate why optimal treatment of Alzheimer’s will require drugs that do more than clear amyloid plaques, says the...

Hired and retired: New appointments in the biopharma industry

02-Dec-2022

By Rachel Arthur

Moderna, Rentschler Biopharma and ViroCell Biologics are among the companies welcoming new faces to top jobs.

Pyxis gets IND clearance from FDA for ADC and immunotherapy candidates

02-Dec-2022

By Jane Byrne

Pyxis Oncology has received clearance for two IND applications from the US Food and Drug Administration (FDA) to initiate two Phase 1 clinical studies.